Evidence map›Paper›PMID 23652733›Full record

ArticleCirculation. Cardiovascular quality and outcomes2013

Trends in vascular risk factor treatment and control in US stroke survivors: the National Health and Nutrition Examination Surveys (1999-2010).

Nilay S Shah, Mark D Huffman, Hongyan Ning, Donald M Lloyd-Jones

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Review
  14. Article
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nilay S ShahNorthwestern University Feinberg School of Medicine, Department of Preventive Medicine, Chicago, IL 60611, USA.
Mark D Huffman
Hongyan Ning
Donald M Lloyd-Jones
Northwestern University · US

Funding

RESEARCH TRAINING IN CVD EPIDEMIOLOGY AND PREVENTIONT32HL069771 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Mercedes Renee Carnethon · 2003 to 2026
$5.9M
Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK)K99HL107749 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HUFFMAN, MARK D · 2012 to 2013
$171k
NHLBI NIH HHS K99 HL107749NHLBI NIH HHS T32 HL069771
6 · The paper itself

Abstract

backgroundTreatment and control of vascular risk factors reduce the likelihood of recurrent stroke. Present nationally representative data are sparse regarding secondary prevention treatment and control rates. METHODS AND

resultsWe evaluated sex- and race-stratified blood pressure, cholesterol, and hemoglobin A1c levels and treatment and control rates in 1154 self-reported stroke survivors from the National Health and Nutrition Examination Surveys 1999 to 2010. We used weighted linear regression to estimate time trends. Participants were 54% to 61% women, 70% to 76% white, and had a mean age of 63 to 66 years. For blood pressure, treatment rates remained unchanged in men, but in women, treatment rates increased from 41% in 1999 to 2000 to 65% in 2009 to 2010 (P=0.03), and control rates increased from 23% to 79% (P=0.03). Treatment rates remained unchanged in non-Hispanic whites, non-Hispanic blacks, and Mexican Americans, although control rates increased in non-Hispanic whites from 50% in 1999 to 2002 to 69% in 2007 to 2010 (P=0.04). For cholesterol, treatment rates increased from 30% to 40% in men (P=0.02) and from 28% to 36% (P<0.01) in women, but control rates increased only in men, from 62% to 87% (P<0.01). Cholesterol treatment rates increased only in non-Hispanic blacks, from 18% to 37% (P=0.02). By sex and race, there was no change in dysglycemia treatment and control.

conclusionsDespite improvements in blood pressure treatment and control and cholesterol treatment for women and cholesterol treatment and control for men, stroke secondary prevention through treatment and control of vascular risk factors remains suboptimal. Urgent action is needed to improve secondary prevention to reduce stroke morbidity and mortality in this high-risk group.

Indexed as

AgedAntihypertensive AgentsBiomarkersBlood PressureCholesterolCross-Sectional StudiesEthnicityFemaleGlycated HemoglobinGuideline AdherenceHealthcare DisparitiesHumansHypoglycemic AgentsHypolipidemic AgentsLinear ModelsMaleAntihypertensive AgentsBiomarkersCholesterolGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsHypolipidemic Agentssecondary preventionstroketreatmenttrends

Identifiers

PMID23652733
PMCPMC10084945
OpenAlexW2548654214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.